| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 05/17/2006 | EP1657255A1 Novel protein and method for producing the protein |
| 05/17/2006 | EP1657252A2 PGC-1, a novel brown fat PPAR gamma coactivator |
| 05/17/2006 | EP1656950A1 Immunotoxins directed against CD33 related surface antigens |
| 05/17/2006 | EP1656455A2 Process for the purification of recombinant polypeptides |
| 05/17/2006 | EP1656444A2 Fermentation medium based on a highly hydrolized protein substrate |
| 05/17/2006 | EP1573313A4 Transgenic mice expressing human cd20 and/or cd16 |
| 05/17/2006 | EP1490394A4 Method and apparatus for the identification and qualification of biomolecules |
| 05/17/2006 | EP1214598B1 Screening for inhibitors of "paired helical filaments" |
| 05/17/2006 | EP1214409B1 Fibroblast growth factor-19 (fgf-19) nucleic acids and polypeptides and methods of use for the treatment of obesity |
| 05/17/2006 | EP1169460B1 Preparation of biologically active molecules |
| 05/17/2006 | EP1124853B1 Anti-petasin antibodies, methods for the production thereof and their use |
| 05/17/2006 | EP1117693B1 Intein mediated peptide ligation |
| 05/17/2006 | EP1067183B1 Novel g protein-coupled receptor proteins |
| 05/17/2006 | EP1025245B1 Rapid generation of stable mammalian cell lines producing high levels of recombinant proteins |
| 05/17/2006 | EP0975668B1 MODIFIED TNFalpha MOLECULES, DNA ENCODING SUCH MODIFIED TNFalpha MOLECULES AND VACCINES COMPRISING SUCH MODIFIED TNFalpha MOLECULES AND DNA |
| 05/17/2006 | EP0923941B1 Remedies for myeloma to be used together with nitrogen mustard antitumor agents |
| 05/17/2006 | EP0807124B1 Monoclonal antibody against flt4 receptor tyrosine kinase and its use in diagnosis and therapy |
| 05/17/2006 | EP0796273B1 Variants of human papilloma virus antigens |
| 05/17/2006 | EP0777490B1 Mutant enterotoxin effective as a non-toxic oral adjuvant |
| 05/17/2006 | CN1774264A Recombinant herpesvirus of turkeys and use thereof |
| 05/17/2006 | CN1774258A Treatment of pulmonary disease |
| 05/17/2006 | CN1772916A Chemical enzymatic process of synthesizing glutathion |
| 05/17/2006 | CN1772905A Recombinant organophosphate degrading enzyme gene and its expression vector and prepn process |
| 05/17/2006 | CN1772897A Cell factor with several functions |
| 05/17/2006 | CN1256591C HCV antigen/antibody combination assay |
| 05/17/2006 | CN1256431C Recombined human parathyroid hormone gene, its expression carrier and preparing method of recombined human parathyroid protein |
| 05/16/2006 | US7045676 producing recombinant protein by inserting into embryo of nonhuman mammal a DNA construct comprising gene encoding protein, said gene being under transcriptional control of milk protein promoter sequence that does not naturally control transcription of gene, transferring embryo to female mammal |
| 05/16/2006 | US7045675 Protein for use in the diagnosis and detection of Niemann-Pick disease |
| 05/16/2006 | US7045615 Nucleic acids encoding JTT-1 protein |
| 05/16/2006 | US7045614 LIM mineralization protein splice variants |
| 05/16/2006 | US7045612 Human methionine synthase reductase: cloning, and methods for evaluating risk of neural tube defects, cardiovascular disease, and cancer |
| 05/16/2006 | US7045611 Nucleic acid molecule, comprising a nucleic acid coding for a polypeptide with chorismate mutase activity |
| 05/16/2006 | US7045605 genetic engineered antibodies, nucleic acids; anticancer agents |
| 05/16/2006 | US7045604 Family of genes encoding apoptosis-related peptides, peptides encoded thereby and methods of use thereof |
| 05/16/2006 | US7045602 Specific antibody directed to active hepatocyte growth factor activator and method for using the same |
| 05/16/2006 | US7045596 Family of genes encoding apoptosis-related peptides, peptides encoded thereby and methods of use thereof |
| 05/16/2006 | US7045593 Using detergents; antiagglomerants; eukaryotic membrane protein |
| 05/16/2006 | US7045509 Proteins and nucleic acids encoding same |
| 05/16/2006 | US7045500 Comprises peptide with heparin and/or lipopolysaccharide binding activity for use as treatment of endotoxic shock and endometriosis, anticoagulant, angiogenesis inhibitor, antiproliferative agent and contraceptive |
| 05/16/2006 | US7045498 Soluble Zcytor11 cytokine receptors |
| 05/16/2006 | US7045355 Genes encoding plant transcription factors |
| 05/16/2006 | US7045346 Nucleic acid constructs useful for glucose regulated production of human insulin in somatic cell lines |
| 05/16/2006 | US7045345 G-coupled receptor showing selective affinity for ATP |
| 05/16/2006 | US7045337 Translation system for use in the generation of protein containing adjusted amino acid sequences |
| 05/16/2006 | US7045334 Nucleotide sequence encoding a benzaldehyde lyase, and process for stereoselectively synthesizing 2-hydroxyketones |
| 05/16/2006 | US7045332 BGL4 β-glucosidase and nucleic acids encoding the same |
| 05/16/2006 | US7045331 EGVII endoglucanase and nucleic acids encoding the same |
| 05/16/2006 | US7045329 Lipoprotein associated phospholipase A2, inhibitors thereof and use of the same in diagnosis and therapy |
| 05/16/2006 | US7045325 32142, 21481, 25964, 21686, novel dehydrogenase molecules and uses therefor |
| 05/16/2006 | US7045318 Recombinant fusion proteins to growth hormone and serum albumin |
| 05/16/2006 | US7045315 Methods for modulating expression of exogenous genes in mammalian systems |
| 05/16/2006 | US7045314 Method for the production of bacterial toxins |
| 05/16/2006 | US7045313 plasmid containing multiple restriction endonuclease sites comprising a ploypeptide foreign to the vaccina virus or other poxvirus, a virus promoter sequence and a DNA segment from a nonessential regin of the vaccina genome; for expression of the foreign gene after cell or animal infection |
| 05/16/2006 | US7045305 targeting probes in living microorganisms or cells by expressing Golgi membrane polypeptide comprising single chain antibody binding ligand that is contacted with a probe/ligand conjugate; detection by fluorescent cell sorting, nuclear magnetic resonance and positron emission tomography |
| 05/16/2006 | US7045302 Expressed ligand-vascular intercellular signaling molecule |
| 05/16/2006 | US7045129 Method of treating cancer including administering a human chimeric antibody specific for the ganglioside GD3 |
| 05/16/2006 | CA2527154A1 Blood-viscosity reducing agent |
| 05/16/2006 | CA2147468C Method for producing polypeptide via bacterial fermentation |
| 05/16/2006 | CA2129183C Bispecific trigger molecules recognizing lymphocyte antigen cd2 and tumor antigens |
| 05/11/2006 | WO2006050491A2 Methods for antibody engineering |
| 05/11/2006 | WO2006050046A2 Dre recombinase and recombinase systems employing dre recombinase |
| 05/11/2006 | WO2006049777A2 Nucleic acid sequences encoding luciferase for expression in filamentous fungi |
| 05/11/2006 | WO2006031937A3 Glycerol-3-phosphate o-acyl transferase promoter for gene expression in oleaginous yeast |
| 05/11/2006 | WO2005019414A3 Insecticidal proteins secreted from bacillus thuringiensis and uses therefor |
| 05/11/2006 | US20060101529 Lymphocyte surface receptor that binds CAML and methods of use thereof |
| 05/11/2006 | US20060100422 Pichia pastoris formate dehydrogenase and uses therefor |
| 05/11/2006 | US20060100420 5-hydroxytryptophol (5-HTOL) derivatives, antibodies, immunoassays and detection of recent alcohol consumption |
| 05/11/2006 | US20060100418 Cultured xenopus cell line expressing mutated apc |
| 05/11/2006 | US20060100417 Isolated human transporter proteins nucleic acid molecules encoding human transporter proteins and uses thereof |
| 05/11/2006 | US20060100416 Novel substitution mutant receptors and their use in an nuclear receptor-based inducible gene expression system |
| 05/11/2006 | US20060100153 HSulf-1 nucleic acids, polypeptides and methods of using |
| 05/11/2006 | US20060100143 Polypeptide |
| 05/11/2006 | US20060099701 Activators of cyclin-dependent kinases |
| 05/11/2006 | US20060099700 Enzymatic polypeptide comprising halogenase activity for use in production of 4-substituted-3-butyric acid derivatives and vicinal cyano, hydroxyl substituted carboxylic acid esters; bioremediation; pollution control |
| 05/11/2006 | US20060099699 Comprises nucleotide sequences coding galactosyltransferase for use in treatment or prevention of aberrant cell surface glycosylation associated with tumor progression |
| 05/11/2006 | US20060099698 Glucose dehydrogenases |
| 05/11/2006 | US20060099689 Use of caspase enzymes for maturation of engineered recombinant polypeptide fusions |
| 05/11/2006 | US20060099688 polypeptides having transferse enzyme activity, used for biosynthesis of polysaccharides; genetic engineering |
| 05/11/2006 | US20060099687 14926 Receptor, a novel G-protein coupled receptor |
| 05/11/2006 | US20060099686 Generation of artificial binding proteins on the basis of ubiquitin proteins |
| 05/11/2006 | US20060099685 Recombinant expression of factor VIII in human cells |
| 05/11/2006 | US20060099684 Polypeptide of given sequence; inhibiting endothelial cell proliferation; restenosis, cancer, eye disorders |
| 05/11/2006 | US20060099683 Isolated hOAT polypeptide |
| 05/11/2006 | US20060099682 Human vanilloid receptors and their uses |
| 05/11/2006 | US20060099681 Human and mouse alkaline ceramidase 1 and skin diseases |
| 05/11/2006 | US20060099680 Yeast transformant into which genes associated with synthesis system of O-fucosylated protein are introduced |
| 05/11/2006 | US20060099679 nucleic acids, vectors, and host cells; monomeric fluorescent proteins with increased photostability and the longest-wavelength emissions (e.g., 649 nm) yet observed for a red fluorescent protein |
| 05/11/2006 | US20060099678 Method of inducing homologous recombination of somatic cell |
| 05/11/2006 | US20060099677 DNA/RNA transduction technology and its clinical and basic applications |
| 05/11/2006 | US20060099676 Mammalian genes involved in rapamycin resistance and tumorgenesis: rapr6 genes |
| 05/11/2006 | US20060099675 Method for preparing an extracellular matrix and its use for tumor cell culture |
| 05/11/2006 | US20060099674 Chromatographic purification of recombinant human erythropoietin |
| 05/11/2006 | US20060099673 Novel recombinant gene expression method by stop codon suppression |
| 05/11/2006 | US20060099672 Polypeptides with a functional binding domain, translocation domain, a therapeutic domain and a non-native protease cleavage site for cleavage in vitro following expression as a single chain; efficient, less dangerous production method; botulinum neurotoxins targeted to specific cell types for example |
| 05/11/2006 | US20060099671 Methods and compositions for generating angiostatin |
| 05/11/2006 | US20060099661 Detection and quantification of intracellular pathogens |
| 05/11/2006 | US20060099658 PCA3, PCA3 genes, and methods of use |
| 05/11/2006 | US20060099655 Cloning of a human cytoplasmic polyadenylation element binding protein (hCPEB) with sequence-specific RNA binding activity; examining reproductive potential of a oocyte; gene expression |
| 05/11/2006 | US20060099640 SLO2 and SLO4, novel potassium channel proteins from human brain |
| 05/11/2006 | US20060099635 Anti-GL50 antibodies |